ORA - Oxford University Research Archive

You searched for:

Oxford, MSD, Clinical Medicine, Structural Genomics Consortium

Tumor Suppressor Protein p53

1 - 8 of 8

1

Journal article

Conformational stability and activity of p73 require a second helix in the tetramerization domain.

Coutandin, D, Löhr, F, Niesen, FH, et al.
2009-12-05

2

Journal article

DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramer.

Deutsch, GB, Zielonka, EM, Coutandin, D, et al.
2011-02-05

3

Journal article

Structural basis for ASPP2 recognition by the tumor suppressor p73.

Canning, P, von Delft, F, Bullock, AN
2012-11-05

4

Journal article

Rescuing the function of mutant p53.

Bullock, AN, Fersht, AR
2001-10-05

5

Journal article

Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.

Lu, M, Breyssens, H, Salter, V, et al.
2013-05-05

6

Journal article

Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.

Bullock, AN, Henckel, J, Fersht, AR
2000-03-05

7

Journal article

The p53 cofactor Strap exhibits an unexpected TPR motif and oligonucleotide-binding (OB)-fold structure.

Adams, CJ, Pike, AC, Maniam, S, et al.
2012-03-05

8

Journal article

Thermodynamic stability of wild-type and mutant p53 core domain.

Bullock, AN, Henckel, J, DeDecker, BS, et al.
1997-12-05

TO TOP